SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...
Second Sight Medical shares jumped to nearly $10 after the FDA approved its Argus2 Retinal Prosthesis System. The regulatory approval arrives as Second Sight works to complete a business combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback